Aβ measurement by enzyme-linked immunosorbent assay.

Area of Science:

• Neuroscience
• Biochemistry
• Pathology

Background:

• Alzheimer's disease (AD) is characterized by neuritic plaques containing amyloid-beta (Aβ) peptide.
• Aβ is derived from the amyloid precursor protein and is implicated in AD pathogenesis.
• Targeting Aβ production and accumulation is a key therapeutic strategy for AD.

Purpose of the Study:

• To describe reliable methods for quantifying Aβ peptide in brain tissue.
• To facilitate research understanding the molecular etiology of Alzheimer's disease.
• To aid in the assessment of potential Aβ-targeting therapeutics.

Main Methods:

• Recovery of both soluble and deposited Aβ from brain tissue.
• Quantitation of Aβ peptide using a sandwich enzyme-linked immunosorbent assay (ELISA).
• Detailed methodology for sensitive and reliable Aβ measurement.

Main Results:

• Established protocols for Aβ peptide recovery from brain homogenates.
• Demonstrated the efficacy of sandwich ELISA for precise Aβ quantitation.
• Provided validated methods for both soluble and deposited forms of Aβ.

Conclusions:

• Enzyme-linked immunosorbent assay (ELISA) is a sensitive and reliable method for Aβ quantitation.
• The described methods are invaluable for Alzheimer's disease research.
• Accurate Aβ measurement is essential for understanding AD pathogenesis and developing treatments.